Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Depreciation & Amortization (CF) (2022 - 2026)

Zentalis Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 5 years, most recently at $151000.0 for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) fell 42.37% year-over-year to $151000.0; the TTM value through Mar 2026 reached $589000.0, down 52.0%, while the annual FY2025 figure was $700000.0, 45.69% down from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 was $151000.0 at Zentalis Pharmaceuticals, up from $118000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $375000.0 in Q3 2022 and troughed at $118000.0 in Q4 2025.
  • A 5-year average of $292117.6 and a median of $327000.0 in 2024 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): increased 4.65% in 2023 and later tumbled 62.78% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $359000.0 in 2022, then fell by 3.06% to $348000.0 in 2023, then fell by 8.91% to $317000.0 in 2024, then tumbled by 62.78% to $118000.0 in 2025, then rose by 27.97% to $151000.0 in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for ZNTL at $151000.0 in Q1 2026, $118000.0 in Q4 2025, and $160000.0 in Q3 2025.